Sandra Gottschling
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
-
- Cancer Cells and Metastasis
Papers in
- Oncology 5
- Cancer Cells and Metastasis 4
-
- Immunotherapy and Immune Responses 1
- Co-authors
- Esther Herpel (9 shared papers)Philipp A. Schnabel (9 shared papers)Felix Herth (7 shared papers)Michael Thomas (5 shared papers)Thomas Muley (6 shared papers)Michael Meister (6 shared papers)Anja Seckinger (3 shared papers)Rainer Saffrich (2 shared papers)
- Journals
- Lung Cancer (4 papers)Blood (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Experimental Hematology (1 paper)Stem Cells (1 paper)
- Partner nations
- GermanyPolandUnited Kingdom
In The Last Decade
Sandra Gottschling
16 papers receiving 437 citations
Peers
Comparison fields: 5 of 63
- Hematology 68
- Oncology 160
- Cancer Research 81
- Genetics 58
- Immunology 89
Countries citing papers authored by Sandra Gottschling
This map shows the geographic impact of Sandra Gottschling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Gottschling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Gottschling more than expected).
Fields of papers citing papers by Sandra Gottschling
This network shows the impact of papers produced by Sandra Gottschling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Gottschling. The network helps show where Sandra Gottschling may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Gottschling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 76 | |
| 2 | 2006 | 73 | |
| 3 | Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer. | 2013 | 52 |
| 4 | 2008 | 43 | |
| 5 | 2013 | 42 | |
| 6 | The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. | 2011 | 40 |
| 7 | 2001 | 32 | |
| 8 | 2012 | 25 | |
| 9 | 2011 | 25 | |
| 10 | Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. | 2013 | 14 |
| 11 | 2012 | 12 | |
| 12 | 2007 | 8 | |
| 13 | 2011 | 6 | |
| 14 | 2004 | 1 | |
| 15 | 2005 | 1 | |
| 16 | 2009 | 1 |
About Sandra Gottschling
Sandra Gottschling is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 16 papers that have together received 451 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Lung Cancer Treatments and Mutations (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Mesenchymal stem cell research (2 papers), Head and Neck Cancer Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), Epigenetics and DNA Methylation (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Hematology (68 citations), Oncology (160 citations), Cancer Research (81 citations), Genetics (58 citations) and Immunology (89 citations). Sandra Gottschling has collaborated with scholars based in Germany, Poland and United Kingdom. Frequent co-authors include Esther Herpel, Philipp A. Schnabel, Felix Herth, Michael Thomas, Thomas Muley, Michael Meister, Anja Seckinger, Rainer Saffrich, U. Krause and Anthony D. Ho. Their work appears in journals such as Lung Cancer, Blood, Arteriosclerosis Thrombosis and Vascular Biology, Experimental Hematology and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.